These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25853833)

  • 21. Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee.
    Fuentes Camps I; Rodríguez A; Agustí A
    Br J Clin Pharmacol; 2018 Jun; 84(6):1384-1388. PubMed ID: 29446851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on unethical use of placebos in randomised trials.
    Michels KB; Rothman KJ
    Bioethics; 2003 Apr; 17(2):188-204. PubMed ID: 12812185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The improper use of research placebos.
    Kottow M
    J Eval Clin Pract; 2010 Dec; 16(6):1041-4. PubMed ID: 20663001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fifth revision of Declaration of Helsinki. Clause 29 forbids trials from using placebos when effective treatment exists.
    Bland JM; Kerr D
    BMJ; 2002 Apr; 324(7343):975. PubMed ID: 11964349
    [No Abstract]   [Full Text] [Related]  

  • 25. Once is not enough: clinical trials in sepsis.
    Sweeney DA; Danner RL; Eichacker PQ; Natanson C
    Intensive Care Med; 2008 Nov; 34(11):1955-60. PubMed ID: 18839140
    [No Abstract]   [Full Text] [Related]  

  • 26. What are the effects of the fifth revision of the Declaration of Helsinki?
    Tollman SM; Bastian H; Doll R; Hirsch LJ; Guess HA
    BMJ; 2001 Dec; 323(7326):1417-23. PubMed ID: 11744569
    [No Abstract]   [Full Text] [Related]  

  • 27. ['Best proven care' not always the best control].
    van der Graaf R; van Thiel GJ; van Delden JJ
    Ned Tijdschr Geneeskd; 2014; 158():A7227; discussion A7227. PubMed ID: 24690518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Confusion over use of placebos in clinical trials.
    Collier J
    BMJ; 1995 Sep; 311(7009):821-2. PubMed ID: 7580477
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk, Helsinki 2000 and the use of placebo in medical research.
    Saunders J; Wainwright P
    Clin Med (Lond); 2003; 3(5):435-9. PubMed ID: 14601942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Registration of observational studies: it is time to comply with the Declaration of Helsinki requirement].
    Dal-Ré R; Delgado M; Bolumar F
    Gac Sanit; 2015; 29(3):228-31. PubMed ID: 25433766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III trials: specific problems associated with the use of a placebo control group.
    Cleophas TJ; Van der Meulen J; Kalmansohn RB
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):47-50. PubMed ID: 9147706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conflict of interest: will it ever end?
    Carney SL
    Intern Med J; 2012 Nov; 42(11):1255-6. PubMed ID: 23157520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Declaration of Helsinki, 2008: implications for stakeholders in research.
    Puri KS; Suresh KR; Gogtay NJ; Thatte UM
    J Postgrad Med; 2009; 55(2):131-4. PubMed ID: 19550060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sponsor-involved statistical analyses in Phase III cancer clinical trials.
    Abi Jaoude J; Kouzy R; Minsky BD; Fuller CD; Yuan Y; Do KA; Taniguchi CM; Ludmir EB
    Int J Cancer; 2020 Dec; 147(12):3579-3581. PubMed ID: 32621758
    [No Abstract]   [Full Text] [Related]  

  • 36. [Routine use of placebos is questioned. Clear standpoint in the Helsinki declaration].
    Dalén P
    Lakartidningen; 2001 Jan; 98(1-2):16-8. PubMed ID: 11213703
    [No Abstract]   [Full Text] [Related]  

  • 37. Declaration of Helsinki revised.
    Reynolds T
    J Natl Cancer Inst; 2000 Nov; 92(22):1801-3. PubMed ID: 11078756
    [No Abstract]   [Full Text] [Related]  

  • 38. Placebo: its action and place in health research today.
    Smoak R
    Sci Eng Ethics; 2004 Jan; 10(1):9-13. PubMed ID: 14986765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Declaration of Helsinki: revising ethical research guidelines for the 21st century.
    Stockhausen K
    Med J Aust; 2000 Mar; 172(6):252-3. PubMed ID: 10860086
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is the placebo still ethically acceptable and scientifically useful in clinical drug experimentation?].
    Mariani L; Ventresca GP
    Clin Ter; 1996 Nov; 147(11):595-8. PubMed ID: 9264914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.